UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000015661
Receipt No. R000018207
Official scientific title of the study Ethanol injection into Marshall vein during catheter ablation for atrial fibrillation
Date of disclosure of the study information 2014/11/11
Last modified on 2016/11/13 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Ethanol injection into Marshall vein during catheter ablation for atrial fibrillation
Title of the study (Brief title) Ethanol injection into Marshall vein
Region
Japan

Condition
Condition atrial fibrillation
Classification by specialty
Cardiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 feasibility, efficacy, safety evaluation
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes success rate of ethanol injection, conduction block at the mitral isthmus
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 ethanol injection into Marshall vein
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >=
Gender Male and Female
Key inclusion criteria Patients who could not have conduction block at mitral isthmus.
Key exclusion criteria Patients who do not have marshall vein
Target sample size 15

Research contact person
Name of lead principal investigator Seiji Takatsuki
Organization Keio University
Division name Department of Cardiology
Address 35 Shinanomachi Shinjukuku
TEL 03-3353-1211
Email seiji.takatsuki@gmail.com

Public contact
Name of contact person Seiji Takatsuki
Organization Keio University
Division name Department of Cardiology
Address 35 Shinanomachi Shinjukuku
TEL 03-3353-1211
Homepage URL
Email seiji.takatsuki@gmail.com

Sponsor
Institute Keio University
Institute
Department

Funding Source
Organization Contribution
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 慶應義塾大学病院

Other administrative information
Date of disclosure of the study information
2014 Year 11 Month 11 Day

Progress
Recruitment status Completed
Date of protocol fixation
2004 Year 11 Month 01 Day
Anticipated trial start date
2014 Year 11 Month 11 Day
Last follow-up date
2015 Year 11 Month 11 Day
Date of closure to data entry
2015 Year 12 Month 11 Day
Date trial data considered complete
2016 Year 06 Month 01 Day
Date analysis concluded
2016 Year 09 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2014 Year 11 Month 11 Day
Last modified on
2016 Year 11 Month 13 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000018207